3344 related articles for article (PubMed ID: 7629806)
1. Synthesis and biological evaluation of 5-fluoro-2'-deoxyuridine phosphoramidate analogs.
Fries KM; Joswig C; Borch RF
J Med Chem; 1995 Jul; 38(14):2672-80. PubMed ID: 7629806
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological activity of novel 5-fluoro-2'-deoxyuridine phosphoramidate prodrugs.
Freel Meyers CL; Hong L; Joswig C; Borch RF
J Med Chem; 2000 Nov; 43(22):4313-8. PubMed ID: 11063625
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activity of N-2,3-dihydroxypropyl-N-4-chlorobutyl nucleoside phosphoramidate prodrugs.
Wu W; Borch RF
Mol Pharm; 2006; 3(4):451-6. PubMed ID: 16889439
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological studies of novel nucleoside phosphoramidate prodrugs.
Tobias SC; Borch RF
J Med Chem; 2001 Dec; 44(25):4475-80. PubMed ID: 11728193
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity of 5-fluoro-5'-O-nitro-2'-deoxyuridine, a new fluorinated pyrimidine derivative, in L1210 cultures.
Roberts D; Franklin P; Odom G; Peck C; Chwang TL
Mol Pharmacol; 1982 Nov; 22(3):760-5. PubMed ID: 6218391
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of 2'-deoxy-2',2'-difluoro-5-halouridine phosphoramidate ProTides.
Quintiliani M; Persoons L; Solaroli N; Karlsson A; Andrei G; Snoeck R; Balzarini J; McGuigan C
Bioorg Med Chem; 2011 Jul; 19(14):4338-45. PubMed ID: 21696963
[TBL] [Abstract][Full Text] [Related]
7. The cytostatic activity of NUC-3073, a phosphoramidate prodrug of 5-fluoro-2'-deoxyuridine, is independent of activation by thymidine kinase and insensitive to degradation by phosphorolytic enzymes.
Vande Voorde J; Liekens S; McGuigan C; Murziani PG; Slusarczyk M; Balzarini J
Biochem Pharmacol; 2011 Sep; 82(5):441-52. PubMed ID: 21658373
[TBL] [Abstract][Full Text] [Related]
8. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies.
Jackman AL; Alison DL; Calvert AH; Harrap KR
Cancer Res; 1986 Jun; 46(6):2810-5. PubMed ID: 2938731
[TBL] [Abstract][Full Text] [Related]
9. Antineoplastic activity of 3'-(chloroethyl)nitrosourea analogues of 2'-deoxyuridine and 2'-deoxy-5-fluorouridine.
Lin TS; Brubaker WF; Wang ZH; Park S; Prusoff WH
J Med Chem; 1986 May; 29(5):862-5. PubMed ID: 2939245
[TBL] [Abstract][Full Text] [Related]
10. Potent inhibition of thymidylate synthase by two series of nonclassical quinazolines.
McNamara DJ; Berman EM; Fry DW; Werbel LM
J Med Chem; 1990 Jul; 33(7):2045-51. PubMed ID: 2362285
[TBL] [Abstract][Full Text] [Related]
11. 3'-O- and 5'-O-Propargyl Derivatives of 5-Fluoro-2'-Deoxyuridine: Synthesis, Cytotoxic Evaluation and Conformational Analysis.
Baraniak D; Baranowski D; Ruszkowski P; Boryski J
Nucleosides Nucleotides Nucleic Acids; 2016; 35(4):178-94. PubMed ID: 26914155
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activity of aromatic amino acid phosphoramidates of 5-fluoro-2'-deoxyuridine and 1-beta-arabinofuranosylcytosine: evidence of phosphoramidase activity.
Abraham TW; Kalman TI; McIntee EJ; Wagner CR
J Med Chem; 1996 Nov; 39(23):4569-75. PubMed ID: 8917645
[TBL] [Abstract][Full Text] [Related]
13. 5-Substituted 2'-deoxyuridines: correlation between inhibition of tumor cell growth and inhibition of thymidine kinase and thymidylate synthetase.
Balzarini J; De Clercq E; Mertes MP; Shugar D; Torrence PF
Biochem Pharmacol; 1982 Nov; 31(22):3673-82. PubMed ID: 7181950
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity of 5-fluoro-2'-deoxyuridine: requirement for reduced folate cofactors and antagonism by methotrexate.
Ullman B; Lee M; Martin DW; Santi DV
Proc Natl Acad Sci U S A; 1978 Feb; 75(2):980-3. PubMed ID: 147465
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and anticancer activity of some 5-fluoro-2'-deoxyuridine phosphoramidates.
Lewandowska M; Ruszkowski P; Chojnacka K; Kleczewska N; Hoffmann M; Kacprzak K; Celewicz L
Bioorg Med Chem; 2016 May; 24(10):2330-41. PubMed ID: 27073055
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, antiviral and cytotoxic activity of 2'-deoxyuridines, 2'-fluoro-2'-deoxyuridines and 2'-arabinouridines containing 5-(1-hydroxy-2-halo-2-ethoxycarbonylethyl)-, 5-(1-hydroxy-2-iodo-2- carboxyethyl)- and 5-[1-hydroxy (or methoxy)-2-iodoethyl] substituents.
Kumar R; Wiebe LI; Knaus EE; Allen TM; Tempest ML
Drug Des Discov; 1992 Feb; 8(3):179-89. PubMed ID: 1326340
[TBL] [Abstract][Full Text] [Related]
17. Quinazoline antifolate thymidylate synthase inhibitors: replacement of glutamic acid in the C2-methyl series.
Marsham PR; Jackman AL; Barker AJ; Boyle FT; Pegg SJ; Wardleworth JM; Kimbell R; O'Connor BM; Calvert AH; Hughes LR
J Med Chem; 1995 Mar; 38(6):994-1004. PubMed ID: 7699716
[TBL] [Abstract][Full Text] [Related]
18. 2-Thio derivatives of dUrd and 5-fluoro-dUrd and their 5'-monophosphates: synthesis, interaction with tumor thymidylate synthase, and in vitro antitumor activity.
Bretner M; Kulikowski T; Dzik JM; BaliĆska M; Rode W; Shugar D
J Med Chem; 1993 Nov; 36(23):3611-7. PubMed ID: 8246229
[TBL] [Abstract][Full Text] [Related]
19. Strategies for the measurement of the inhibitory effects of thymidine analogs on the activity of thymidylate synthase in intact murine leukemia L1210 cells.
Balzarini J; De Clercq E
Biochim Biophys Acta; 1984 Feb; 785(1-2):36-45. PubMed ID: 6696920
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced alpha1-acid glycoprotein binding.
Curtin NJ; Bowman KJ; Turner RN; Huang B; Loughlin PJ; Calvert AH; Golding BT; Griffin RJ; Newell DR
Br J Cancer; 1999 Aug; 80(11):1738-46. PubMed ID: 10468290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]